Results 61 to 70 of about 192,096 (187)

Evaluating the Specificity of Antisense Oligonucleotide Conjugates: A DNA ARRAY ANALYSIS [PDF]

open access: yes, 2002
Antisense oligonucleotides are potentially powerful tools for selective control of cellular and viral gene expression. Crucial to successful application of this approach is the specificity of the oligonucleotide for the chosen RNA target.
Fisher, Michael H.   +5 more
core   +1 more source

An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis

open access: yesJournal of Lipid Research, 2005
High levels of plasma apolipoprotein B-100 (apoB-100), the principal apolipoprotein of LDL, are associated with cardiovascular disease. We hypothesized that suppression of apoB-100 mRNA by an antisense oligonucleotide (ASO) would reduce LDL cholesterol ...
Rosanne M. Crooke   +5 more
doaj   +1 more source

Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line

open access: yesStem Cell Research, 2019
Spinocerebellar ataxia type 3 (SCA3) is a fatal, late-onset neurodegenerative disorder characterized by selective neuropathology in the brainstem, cerebellum, spinal cord, and substantia nigra.
Lauren R. Moore   +9 more
doaj   +1 more source

Meeting report: antisense oligonucleotides.

open access: yesHaematologica, 1994
The use of antisense oligonucleotides as a therapeutic tool in modulating gene expression represents a newly established strategy for treating diseases. Such oligomers may be designed to complement a region of a specific gene or messenger RNA. Using this approach, oligonucleotides can serve as a potential block of transcription or translation through ...
G, Martinelli, S, Ferrari
openaire   +3 more sources

Protocol for inducing severe Scn2a insufficiency in mice by intracerebroventricular antisense oligonucleotide injection

open access: yesSTAR Protocols
Summary: SCN2A loss-of-function variants cause a range of neurodevelopmental disorders. Here, we present a protocol to induce severe Scn2a insufficiency in mice.
Melody Li, Bernd Kuhn
doaj   +1 more source

Schematic of the tandem antisense oligonucleotide approach.

open access: yes, 2015
WT and Mut mRNA can interact with the gapmer or inhibitor, resulting in the formation of the most favorable thermodynamically duplexes (WT RNA/inhibitor and Mut RNA/gapmer).
Jolanta Lisowiec-Wachnicka (823327)   +4 more
core   +1 more source

MOESM1 of Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate

open access: yes, 2018
Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide ...
Cathy Chen (5816591)   +13 more
core   +1 more source

Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex

open access: yes, 1999
Antisense oligonucleotides, and particularly those with phosphorothioate backbones, have emerged as potential gene specific therapeutic agents and are currently undergoing evaluation in clinical trials for a variety of diseases.
Stein, Cy A.   +11 more
core   +1 more source

Antisense oligonucleotide development for the treatment of muscular dystrophies

open access: yes, 2015
Introduction: Depending upon the chemistry and annealing target, antisense oligonucleotides can be used to modify gene expression through several distinct modes of action.
Bao, T.L.   +3 more
core  

Design of antisense oligonucleotides

open access: yesFolia Pharmacologica Japonica, 2016
Satoshi, Obika, Yuuya, Kasahara
openaire   +3 more sources

Home - About - Disclaimer - Privacy